Group 1 - Core viewpoint: Yinos BioTech Co., Ltd. has seen a stock price increase of 5.15%, reaching 45.13 CNY per share, with a total market capitalization of 6.362 billion CNY as of October 27 [1] - Company overview: Yinos BioTech, established on May 12, 2010, is located in the China (Shanghai) Pilot Free Trade Zone and specializes in providing non-clinical research services in the biopharmaceutical sector, with 96.31% of its revenue coming from non-clinical services [1] - Revenue breakdown: The company's revenue composition includes 96.31% from non-clinical services, 3.42% from clinical services, and 0.27% from other sources [1] Group 2 - Major shareholder: Jiashi Fund's Jiashi Medical Health Stock A (005303) has entered the top ten circulating shareholders of Yinos, holding 344,300 shares, which is 1.22% of the circulating shares [2] - Fund performance: Jiashi Medical Health Stock A has achieved a year-to-date return of 41.06%, ranking 1050 out of 4219 in its category, and a one-year return of 34.73%, ranking 1293 out of 3877 [2] - Fund manager details: The fund manager, Sun Xiaohui, has a tenure of 200 days with a best return of 36.44%, while the other manager, Hao Miao, has a tenure of 6 years and 286 days with a best return of 183.83% [3]